Literature DB >> 9753429

Crystal structure of tyrosine hydroxylase with bound cofactor analogue and iron at 2.3 A resolution: self-hydroxylation of Phe300 and the pterin-binding site.

K E Goodwill1, C Sabatier, R C Stevens.   

Abstract

TyrOH is a non-heme iron enzyme which uses molecular oxygen to hydroxylate tyrosine to form L-dihydroxyphenylalanine (L-DOPA), and tetrahydrobiopterin to form 4a-hydroxybiopterin, in the rate-limiting step of the catecholamine biosynthetic pathway. The 2.3 A crystal structure of the catalytic and tetramerization domains of rat tyrosine hydroxylase (TyrOH) in the presence of the cofactor analogue 7,8-dihydrobiopterin and iron shows the mode of pterin binding and the proximity of its hydroxylated 4a carbon to the required iron. The pterin binds on one face of the large active-site cleft, forming an aromatic pi-stacking interaction with Phe300. This phenylalanine residue of TyrOH is found to be hydroxylated in the meta position, most likely through an autocatalytic process, and to consequently form a hydrogen bond to the main-chain carbonyl of Gln310 which anchors Phe300 in the active site. The bound pterin forms hydrogen bonds from N-8 to the main-chain carbonyl of Leu295, from O-4 to Tyr371 and Glu376, from the C-1' OH to the main-chain amides of Leu294 and Leu295, and from the C-2' hydroxyl to an iron-coordinating water. The part of the pterin closest to the iron is the O-4 carbonyl oxygen at a distance of 3.6 A. The iron is 5.6 A from the pterin 4a carbon which is hydroxylated in the enzymatic reaction. No structural changes are observed between the pterin bound and the nonliganded enzyme. On the basis of these structures, molecular oxygen could bind in a bridging position optimally between the pterin C-4a and iron atom prior to substrate hydroxylation. This structure represents the first report of close interactions between pterin and iron in an enzyme active site.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9753429     DOI: 10.1021/bi981462g

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  25 in total

1.  Inhibition and covalent modification of tyrosine hydroxylase by 3,4-dihydroxyphenylacetaldehyde, a toxic dopamine metabolite.

Authors:  Lydia M Mexas; Virginia R Florang; Jonathan A Doorn
Journal:  Neurotoxicology       Date:  2011-04-14       Impact factor: 4.294

2.  Self-hydroxylation of taurine/alpha-ketoglutarate dioxygenase: evidence for more than one oxygen activation mechanism.

Authors:  Kevin D Koehntop; Sudha Marimanikkuppam; Matthew J Ryle; Robert P Hausinger; Lawrence Que
Journal:  J Biol Inorg Chem       Date:  2005-12-01       Impact factor: 3.358

3.  Effects of ligands on the mobility of an active-site loop in tyrosine hydroxylase as monitored by fluorescence anisotropy.

Authors:  Giri R Sura; Mauricio Lasagna; Vijay Gawandi; Gregory D Reinhart; Paul F Fitzpatrick
Journal:  Biochemistry       Date:  2006-08-08       Impact factor: 3.162

Review 4.  Dioxygen activation by nonheme iron enzymes with the 2-His-1-carboxylate facial triad that generate high-valent oxoiron oxidants.

Authors:  Subhasree Kal; Lawrence Que
Journal:  J Biol Inorg Chem       Date:  2017-01-10       Impact factor: 3.358

5.  Single turnover kinetics of tryptophan hydroxylase: evidence for a new intermediate in the reaction of the aromatic amino acid hydroxylases.

Authors:  Jorge Alex Pavon; Bekir Eser; Michaela T Huynh; Paul F Fitzpatrick
Journal:  Biochemistry       Date:  2010-09-07       Impact factor: 3.162

Review 6.  Complex molecular regulation of tyrosine hydroxylase.

Authors:  Izel Tekin; Robert Roskoski; Nurgul Carkaci-Salli; Kent E Vrana
Journal:  J Neural Transm (Vienna)       Date:  2014-05-28       Impact factor: 3.575

7.  Phototactic personality in fruit flies and its suppression by serotonin and white.

Authors:  Jamey S Kain; Chris Stokes; Benjamin L de Bivort
Journal:  Proc Natl Acad Sci U S A       Date:  2012-11-13       Impact factor: 11.205

8.  Effects of mutations in tyrosine hydroxylase associated with progressive dystonia on the activity and stability of the protein.

Authors:  Montserrat Royo; S Colette Daubner; Paul F Fitzpatrick
Journal:  Proteins       Date:  2005-01-01

9.  Spectroscopy and kinetics of wild-type and mutant tyrosine hydroxylase: mechanistic insight into O2 activation.

Authors:  Marina S Chow; Bekir E Eser; Samuel A Wilson; Keith O Hodgson; Britt Hedman; Paul F Fitzpatrick; Edward I Solomon
Journal:  J Am Chem Soc       Date:  2009-06-10       Impact factor: 15.419

10.  Targeting the progression of Parkinson's disease.

Authors:  J L George; S Mok; D Moses; S Wilkins; A I Bush; R A Cherny; D I Finkelstein
Journal:  Curr Neuropharmacol       Date:  2009-03       Impact factor: 7.363

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.